Sartorius Stedim Biotech S.A. (LON:0RG8)

Sartorius Stedim Biotech Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,763	15,185	19,155	24,732	37,348	24,050
Market Cap Growth	-32.44%	-20.72%	-22.55%	-33.78%	55.29%	108.47%
Enterprise Value	18,698	17,158	22,373	25,691	37,777	24,225
Last Close Price	169.50	154.43	206.48	270.79	408.40	258.27
PE Ratio	98.08	104.87	71.14	31.83	107.31	79.91
PS Ratio	7.01	6.61	7.95	7.98	15.40	14.05
PB Ratio	5.00	4.56	8.26	11.09	25.66	18.37
P/TBV Ratio	-	-	-	46.41	163.54	112.24
P/FCF Ratio	34.33	38.63	80.91	153.46	117.67	104.17
P/OCF Ratio	22.78	22.53	29.57	45.54	63.35	64.39
EV/Sales Ratio	7.65	7.46	9.29	8.29	15.58	14.16
EV/EBITDA Ratio	31.89	32.97	39.20	24.20	43.61	46.83
EV/EBIT Ratio	52.24	52.40	54.93	27.47	48.88	53.74
EV/FCF Ratio	38.30	43.65	94.51	159.41	119.02	104.93
Debt / Equity Ratio	0.73	0.71	1.38	0.45	0.36	0.40
Debt / EBITDA Ratio	4.23	4.38	5.39	0.93	0.60	1.00
Debt / FCF Ratio	5.03	6.04	13.50	6.25	1.66	2.28
Asset Turnover	0.34	0.35	0.43	0.78	0.85	0.81
Inventory Turnover	2.06	2.01	1.62	1.85	2.13	2.27
Quick Ratio	1.04	1.05	0.49	0.53	0.59	0.59
Current Ratio	1.85	1.85	1.51	1.61	1.40	1.54
Return on Equity (ROE)	5.25%	5.33%	12.05%	41.43%	25.94%	25.56%
Return on Assets (ROA)	3.19%	3.10%	4.59%	14.62%	16.90%	13.38%
Return on Capital (ROIC)	3.81%	3.74%	5.86%	21.93%	26.10%	18.63%
Return on Capital Employed (ROCE)	5.80%	5.40%	6.90%	26.20%	31.60%	22.00%
Earnings Yield	1.02%	0.95%	1.41%	3.14%	0.93%	1.25%
FCF Yield	2.91%	2.59%	1.24%	0.65%	0.85%	0.96%
Dividend Yield	0.36%	0.37%	0.29%	0.47%	0.26%	0.24%
Payout Ratio	32.84%	38.32%	42.77%	13.25%	15.13%	9.33%
Buyback Yield / Dilution	-3.64%	-5.01%	0.00%	0.01%	0.00%	-0.00%
Total Shareholder Return	-3.28%	-4.64%	0.29%	0.49%	0.26%	0.23%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.